Ignite Creation Date:
2024-05-05 @ 6:59 PM
Last Modification Date:
2024-10-26 @ 9:39 AM
Study NCT ID:
NCT00580021
Status:
WITHDRAWN
Last Update Posted:
2016-01-28
First Post:
2007-12-19
Brief Title:
Clinical Outcomes in Hereditary Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Clinical Outcomes in Hereditary Cancer
Status:
WITHDRAWN
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare the clinical characteristics and post-surgical outcomes overall survivalof pancreatic cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2
Compare the clinical characteristics and outcomes time to progression of breast cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 receiving paclitaxel chemotherapy for metastatic disease
Compare the clinical characteristics and outcomes time to progression of breast cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 receiving paclitaxel chemotherapy for metastatic disease
Detailed Description:
Compare the clinical characteristics and post-surgical outcomes overall survivalof pancreatic cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2
Compare the clinical characteristics and outcomes time to progression of breast cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 receiving paclitaxel chemotherapy for metastatic disease
Compare the clinical characteristics and outcomes time to progression of breast cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 receiving paclitaxel chemotherapy for metastatic disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None